06

Research

Basic & Translational Research Program

 

 

UROLOGY RESEARCH AT THE UNIVERSITY OF CHICAGO

 

The University of Chicago has a rich tradition in urologic research.  From the identification of testosterone in the 1920s, to Dr. Charles Huggins’ Nobel-winning discoveries on the role of hormones in prostate cancer treatment in the 1940s, to the identification of the Androgen Receptor in the 1980s, UChicago research has led the way in the treatment of benign disease and cancer.  Our focus is on the patients and how we, as scientists, can improve their lives.  Our other focus is on training the next generation of urologists and urologic researchers to become leaders in the urologic community. 

 

Our research efforts are directed towards improving the quality of life of patients with cancer by developing, advancing, and subsequently offering state-of-the-art treatments to patients with urologic diseases.  This occurs via basic discovery research, translational approaches, and helping to improve current paradigms to incorporate new technologies and concepts.  



THE UROLOGY RESEARCH LABORATORY AT THE UNIVERSITY OF CHICAGO

 

The Urology Research Laboratory is comprised of several state-of-the art research laboratories totaling over 3,000 square feet of space. It is equipped for state of the art molecular and cellular biology studies, development and maintenance of stable cell lines and primary cultures, biochemical and immunochemical studies, and molecular analysis of clinical specimens. We also have access to all of the state-of-the-art core facilities on campus (https://osrf.uchicago.edu).

 

Research is directed by Dr. Donald Vander Griend Ph.D. with research interests on the role of stem cells and development in prostate cancer and BPH initiation and progression (orcid.org/0000-0003-4421-5698).   The objective of the Urology Research Lab is to nurture creative, innovative researchers who ask complex scientific questions and take the risks necessary to revolutionize medicine and urologic disease management.

 

Dr. Vander Griend also oversees the resident research year, helping guide and enable urology residents to conduct robust and high-impact research on a topic of interest.  This includes monthly research seminars and helping residents utilize the significant research infrastructure at the University of Chicago.

 

 

Don Vander Griend, PhD.

Oncology Research

 

Carrie Rinker-Schaeffer, PhD.

Oncology Research

 

Walter Stadler, M.D.
Medical Oncology Research

 

Diane Yamada, M.D.
Gynecologic Oncology Research